Anagenics Ltd (AN1) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.286x

Based on the latest financial reports, Anagenics Ltd (AN1) has a cash flow conversion efficiency ratio of -0.286x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-649.97K ≈ $-459.90K USD) by net assets (AU$2.27 Million ≈ $1.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Anagenics Ltd's balance sheet to measure how much of total assets are equity-financed.

Anagenics Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Anagenics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AN1 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Anagenics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anagenics Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tianci International, Inc. Common Stock
NASDAQ:CIIT
-0.002x
Samchai Steel Industries Public Company Limited
BK:SAM
-0.061x
Conferize A/S
CO:CONFRZ
-0.072x
Bold Ventures Inc
V:BOL
-0.065x
Magic Empire Global Limited
NASDAQ:MEGL
-0.038x
Astrotech Corp
NASDAQ:ASTC
-0.228x
Tantech Holdings Ltd
NASDAQ:TANH
-0.022x
Polar Capital Global Financials Trust plc
LSE:PCFT
0.010x

Annual Cash Flow Conversion Efficiency for Anagenics Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Anagenics Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Anagenics Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$1.83 Million
≈ $1.29 Million
AU$-1.58 Million
≈ $-1.12 Million
-0.863x -34.52%
2024-06-30 AU$2.71 Million
≈ $1.92 Million
AU$-1.74 Million
≈ $-1.23 Million
-0.641x -220.49%
2023-06-30 AU$8.90 Million
≈ $6.29 Million
AU$-1.78 Million
≈ $-1.26 Million
-0.200x +34.30%
2022-06-30 AU$8.29 Million
≈ $5.87 Million
AU$-2.53 Million
≈ $-1.79 Million
-0.305x +22.73%
2021-06-30 AU$10.43 Million
≈ $7.38 Million
AU$-4.11 Million
≈ $-2.91 Million
-0.394x +3.61%
2020-06-30 AU$9.81 Million
≈ $6.94 Million
AU$-4.01 Million
≈ $-2.84 Million
-0.409x +59.63%
2019-06-30 AU$5.86 Million
≈ $4.14 Million
AU$-5.93 Million
≈ $-4.20 Million
-1.013x +57.27%
2018-06-30 AU$1.86 Million
≈ $1.31 Million
AU$-4.40 Million
≈ $-3.11 Million
-2.371x -156.64%
2017-06-30 AU$4.40 Million
≈ $3.11 Million
AU$-4.06 Million
≈ $-2.87 Million
-0.924x -70.01%
2016-06-30 AU$4.69 Million
≈ $3.32 Million
AU$-2.55 Million
≈ $-1.80 Million
-0.543x +34.34%
2015-06-30 AU$3.77 Million
≈ $2.67 Million
AU$-3.12 Million
≈ $-2.21 Million
-0.828x -109.28%
2014-06-30 AU$5.66 Million
≈ $4.01 Million
AU$-2.24 Million
≈ $-1.58 Million
-0.395x -44.41%
2013-06-30 AU$5.31 Million
≈ $3.75 Million
AU$-1.45 Million
≈ $-1.03 Million
-0.274x +67.46%
2012-06-30 AU$2.09 Million
≈ $1.48 Million
AU$-1.76 Million
≈ $-1.24 Million
-0.841x +26.36%
2011-06-30 AU$2.04 Million
≈ $1.44 Million
AU$-2.33 Million
≈ $-1.65 Million
-1.143x -178.85%
2010-06-30 AU$2.85 Million
≈ $2.02 Million
AU$-1.17 Million
≈ $-826.04K
-0.410x +72.49%
2009-06-30 AU$738.65K
≈ $522.64K
AU$-1.10 Million
≈ $-778.46K
-1.489x +41.77%
2008-06-30 AU$615.63K
≈ $435.60K
AU$-1.57 Million
≈ $-1.11 Million
-2.558x -35.58%
2007-06-30 AU$1.53 Million
≈ $1.08 Million
AU$-2.89 Million
≈ $-2.05 Million
-1.886x -364.75%
2006-06-30 AU$5.59 Million
≈ $3.95 Million
AU$-2.27 Million
≈ $-1.61 Million
-0.406x --

About Anagenics Ltd

AU:AN1 Australia Household & Personal Products
Market Cap
$4.88 Million
AU$6.90 Million AUD
Market Cap Rank
#28599 Global
#1523 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.70
About

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pac… Read more